Evogene Ltd. (NASDAQ:EVGN) will be discussing 3Q20 financial results with the investment community.on 18th November 2020 at 9:00 AM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.evogene.com
Investors who wish to participate in the conference call may call, 1-888-281-1167 U.S. or +972-3-918-0609 Outside U.S.
Earnings Expectation
Evogene Ltd. is expected to report third quarter earnings results, before market open, on Wednesday 18th November 2020.
Evogene Ltd., a biotechnology company, engages in developing various products for various life science markets through the use of computational predictive biology platform in the United States, Germany, and internationally. It discovers and develops products in various areas, including ag-chemicals, ag-biologicals, seed traits, integrated castor oil ag-solutions, and human microbiome-based therapeutics. The company operates through three segments: Evogene, Evofuel, and Biomica.
